Market revenue in 2024 | USD 222.6 million |
Market revenue in 2030 | USD 242.3 million |
Growth rate | 1.4% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 53.95% in 2024. Horizon Databook has segmented the France hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
In France, the HAI diagnostics market is witnessing steady growth, driven by rising awareness about hospital-acquired infections among healthcare professionals and patients alike. The French government has implemented various initiatives aimed at improving infection control practices across hospitals, which has significantly influenced the demand for advanced diagnostic technologies.
The market is characterized by a growing preference for immunoassays and molecular diagnostics that provide rapid results, thereby facilitating timely clinical decisions. French companies such as bioMérieux are key players in this sector, leveraging their expertise in infectious disease diagnostics to innovate and expand their product offerings.
The competitive environment is marked by a focus on enhancing test sensitivity and specificity while reducing turnaround times for results. Partnerships between public health institutions and private companies are fostering advancements in HAI diagnostics, ensuring that France remains competitive within the European landscape.
Horizon Databook provides a detailed overview of country-level data and insights on the France hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into France hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account